Moberg Pharma AB (publ) (STO: MOB)

Sweden flag Sweden · Delayed Price · Currency is SEK
9.89
+0.36 (3.78%)
Jan 20, 2025, 5:29 PM CET
-36.23%
Market Cap 461.56M
Revenue (ttm) 8.78M
Net Income (ttm) -18.25M
Shares Out 46.69M
EPS (ttm) -0.55
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 173,112
Average Volume 544,132
Open 9.56
Previous Close 9.53
Day's Range 9.51 - 10.08
52-Week Range 6.34 - 40.90
Beta 0.93
RSI 36.37
Earnings Date Feb 11, 2025

About Moberg Pharma AB

Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products primarily in Sweden. It develops MOB-015, which has completed Phase III clinical trial for the treatment of nail fungus. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. Moberg Pharma AB (publ) was incorporated in 2006 and is headquartered in Bromma, Sweden. [Read more]

Sector Healthcare
Founded 2006
Employees 10
Stock Exchange Nasdaq Stockholm
Ticker Symbol MOB
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.